NERM
WST icon

New England Research & Management’s West Pharmaceutical WST Stock Holding History

New England Research & Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,206
Closed -$374K – 193
2015
Q1 		$374K Hold
6,206
– – 0.32% 117
2014
Q4 		$330K Sell
6,206
-11,750
-65% -$588K 0.28% 133
2014
Q3 		$804K Sell
17,956
-850
-5% -$36.1K 0.7% 53
2014
Q2 		$793K Buy
+18,806
New +$805K 0.71% 59

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

New England Research & Management's WST Position: Q2 2015 in Review

New England Research & Management sold out of West Pharmaceutical (WST) in Q2 2015, closing a stake of 6,206 shares — an estimated $374K sold.

New England Research & Management first reported a position in WST in Q2 2014 and held it in 4 quarters. The position peaked at $804K in Q3 2014. 219 funds tracked by Wall St. Rank hold WST as of Q2 2015.

  • New England Research & Management reported no remaining West Pharmaceutical position as of Q2 2015 after selling out during the quarter.
  • New England Research & Management sold 6,206 West Pharmaceutical shares in Q2 2015, an estimated $374K.
  • New England Research & Management first reported a position in West Pharmaceutical in Q2 2014 and held it in 4 quarters.
  • New England Research & Management's West Pharmaceutical position peaked at $804K in Q3 2014.
  • 219 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2015.

Based on New England Research & Management's 13F filing for Q2 2015, filed 7 Jul 2015.